Robot-Assisted Retroperitoneal Lymph Node Dissection (RPLND)

Ralph Grauer, Scott Eggener, John P. Sfakianos

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Testicular cancer is a disease with excellent cure rates, especially if discovered early in the disease course. Treatment can include a combination of surgery, chemotherapy, and radiation. In this chapter, we discuss the role of and the evidence for robot-assisted retroperitoneal lymph node dissection in the management of testicular cancer. We conclude with an overview of the robotic surgical technique.

Original languageEnglish
Title of host publicationRobotic Urologic Surgery
Subtitle of host publicationThird Edition
PublisherSpringer International Publishing
Pages879-885
Number of pages7
ISBN (Electronic)9783031003639
ISBN (Print)9783031003622
DOIs
StatePublished - 1 Jan 2022

Keywords

  • Dissection
  • Lymph node
  • Oncology
  • Retroperitoneal
  • Robot-assisted
  • Testicular cancer
  • Urologic oncology

Fingerprint

Dive into the research topics of 'Robot-Assisted Retroperitoneal Lymph Node Dissection (RPLND)'. Together they form a unique fingerprint.

Cite this